Abstract
This paper presents a novel one-step process for converting a liquid stabilized nano-suspension into a solid formulation via hot-melt extrusion combined with an internal devolatilization process (nano-extrusion, NANEX). A polymer (Soluplus®) was fed into the extruder and molten, after which a stable nano-suspension was added via side-feeding devices. The solvent (water) was removed by devolatilization and the polymer solidified at the outlet. The solid material can be tableted or filled in a capsule directly. The results showed that the obtained extrudates comprised nanocrystals in the de-aggregated form, confirming that a solid nano-formulation was prepared. This method is capable of overcoming many of the problems associated with other processes involving solid nano-dosage forms and poses a straightforward approach towards manufacturing such products.
REFERENCES
Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm. 2004;284:109–22.
Gardner CR, Walsh CT, Almarsson O. Drugs as materials: valuing physical form in drug discovery. Nat Rev Drug Discov. 2004;3:926–34.
Prentis R, Lis Y, Walker SR. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985). Brit J Clin Pharmacol. 1988;25(3):387–96.
Müller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47:3–19.
Sarkari M, Brown J, Chen X, Swinnea S, Williams RO, Johnston KP. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm. 2002;243:17–31.
Chen X, Young TJ, Sarkari M, Williams RO, Johnston KP. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm. 2002;242:3–14.
Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62:1569–79.
Liversidge GG, Conzentino P. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm. 1995;125:309–13.
Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18:113–20.
Müller R, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int J Pharm. 1998;160:229–37.
Krause KP, Müller RH. Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation. Int J Pharm. 2001;214:21–4.
Bhakay A, Davé R, Bilgili E. Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating. Powder Technol. 2012. doi:10.1016/j.powtec.2011.12.066
Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm. 2008;364:64–75.
Liversidge G, Cundy K. Surface modified drug nanoparticles. US Patent 5145684. 1992.
Fasano A. Innovative strategies for the oral delivery of drugs and peptides. Trends Biotechnol. 1998;16:152–7.
Chingunpituk J. Nanosuspension technology for drug delivery. Walailak J Sci Technol. 2011;4:139–53.
Müller R, Becker R, Kruss B, Peters K. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution. US Patent 5,858,410. 1999
Müller RH, Böhm BHL, Grau MJ. Nanosuspensions: a formulation approach for poorly soluble drugs and poorly bioavailable drugs. In: Wise D, editor. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000. p. 345–57.
Roblegg E, Jäger E, Hodzic A, Koscher G, Mohr S, Zimmer A, et al. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur J Pharm Biopharm. 2011;79:635–45.
Ramirez-Garcia S, Chen L, Morris MA, Dawson KA. A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. Nanoscale. 2011;3:4617–24.
Müller RH. Zetapotential und Partikelladung in der Laborpraxis. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, editor. 1996.
Kolter K, Karl M, Gryczke A. Hot-melt extrusion with BASF pharma polymers. BASF SE, Pharma Ingredients & Services; 67056 Ludwigshafen, Germany; 2012.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khinast, J., Baumgartner, R. & Roblegg, E. Nano-extrusion: a One-Step Process for Manufacturing of Solid Nanoparticle Formulations Directly from the Liquid Phase. AAPS PharmSciTech 14, 601–604 (2013). https://doi.org/10.1208/s12249-013-9946-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-013-9946-0